Recent Progress and Advances in HGF/MET-Targeted Therapeutic Agents for Cancer Treatment

Author： Zhang Yilong   Jain Rajul K.   Zhu Min  

Publisher： MDPI

E-ISSN： 2227-9059|3|1|149-181

ISSN： 2227-9059

Source： Biomedicines, Vol.3, Iss.1, 2015-03, pp. : 149-181

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer

By Della Corte Carminia Maria   Fasano Morena   Papaccio Federica   Ciardiello Fortunato   Morgillo Floriana  

Biomedicines, Vol. 2, Iss. 4, 2014-11 ,pp. : 345-358

MDPI

Access to resources Recommend Favorite

Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment

By Bignucolo Alessia   De Mattia Elena   Cecchin Erika   Roncato Rossana   Toffoli Giuseppe  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1522-1522

MDPI

Access to resources Recommend Favorite

Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment

By Lin Jung-Chun  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2017-12 ,pp. : 75-75

MDPI

Access to resources Recommend Favorite

The Place of Targeted Agents in the Treatment of Elderly Patients with Metastatic Colorectal Cancer

By Matikas Alexios   Asimakopoulou Natalia   Georgoulias Vassilis   Souglakos John  

Cancers, Vol. 7, Iss. 1, 2015-03 ,pp. : 439-449

MDPI

Access to resources Recommend Favorite

HGF–MET Cascade, a Key Target for Inhibiting Cancer Metastasis: The Impact of NK4 Discovery on Cancer Biology and Therapeutics

By Mizuno Shinya   Nakamura Toshikazu  

International Journal of Molecular Sciences, Vol. 14, Iss. 1, 2013-01 ,pp. : 888-919

MDPI

Access to resources Recommend Favorite